The effect of cigarette smoking on the hypnotic efficacy of propofol

Anaesthesia

Volumn 61, Issue 9, 2006, Pages 826-831

  Lysakowski, Christopher ^a   Dumont, L ^a   Czarnetzki, C ^a   Bertrand, D ^b   Tassonyi, E ^a   Tramer M R ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE; PROPOFOL;

ADULT; AGE; AGED; ARTICLE; BISPECTRAL INDEX; BODY HEIGHT; BODY WEIGHT; CIGARETTE SMOKING; CLINICAL ARTICLE; CONSCIOUSNESS LEVEL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; FEMALE; GENDER; HUMAN; HYPNOSIS; INFUSION SYSTEM; MALE; OBSERVATIONAL STUDY; REFERENCE VALUE; SEDATION;

ADULT; ANTHROPOMETRY; CONSCIOUSNESS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; PROPOFOL; SMOKING;

EID: 33747116926     PISSN: 00032409     EISSN: 13652044     Source Type: Journal    
DOI: 10.1111/j.1365-2044.2006.04747.x     Document Type: Article

References (30)

1. Kroeker KA, Beattie WS, Yang H. Neuromuscular blockade in the setting of chronic nicotine exposure. Anesthesiology 1994; 81: A1120.
2. Teiria H, Rautoma P, Yli-Hankala A. Effects of smoking on dose requirements of vecuronium. British Journal of Anaesthesia 1996; 76: 154-5.
3. Latorre F, de Almeida MC, Stanek A, Kleemann PP. The interaction between rocuronium and smoking. The effect of smoking on neuromuscular transmission after Rocuronium. Der Anaesthesist 1997; 46: 493-5.
4. Teiria H, Yli-Hankala A, Neuvonen PJ, Olkkola KT. Cigarette smoking does not affect thiopentone pharmacodynamic or pharmacokinetic behaviour. Canadian Journal of Anaesthesia 1997; 44: 1269-74.
5. Ochs HR, Greenblatt DJ, Knuchel M. Kinetics of diazepam, midazolam, and lorazepam in cigarette smokers. Chest 1985; 87: 223-6.
6. Dilger JP. The effects of general anaesthetics on ligand-gated ion channels. British Journal of Anaesthesia 2002; 89: 41-51.
7. McMahon LL, Yoon KW, Chiappinelli VA. Nicotinic receptor activation facilitates GABAergic neurotransmission in the avian lateral spiriform nucleus. Neuroscience 1994; 59: 689-98.
8. Salmi E, Kaisti KK, Metsahonkala L, et al. Sevoflurane and propofol increase 11C-flumazenil binding to gamma-aminobutyric acid A receptors in humans. Anesthesia and Analgesia 2004; 99: 1420-6.
9. Schnider TW, Minto CF, Gambus PL, et al. The influence of method of administration and covariates on the pharmacokinetics of propofol in adult volunteers. Anesthesiology 1998; 88: 1170-82.
10. Struys M, Versichelen L, Thas O, Herregods L, Rolly G. Comparison of computer-controlled administration of propofol with two manually controlled infusion techniques. Anaesthesia 1997; 53: 41-50.
11. Lin CS, Li YC, Mok MS, Wu CC, Chiu HW, Lin YH. Neural network modelling to predict the hypnotic effect of propofol bolus induction. Proceedings of the AMIA Symposium 2002, 450-4.
12. Rampil IN. A primer for EEG signals processing in anesthesia. Anesthesiology 1998; 89: 980-1002.
13. Chernik DA, Gillings D, Laine H, et al. Validity and reliability of the Observer's Assessment of Alertness/Sedation Scale: Study with intravenous midazolam. Journal of Clinical Psychopharmacology 1990; 10: 244-51.
14. Pirkle JL, Flegal KM, Bernert JT, Brody DJ, Etzel RA, Maurer KR. Exposure of the US population to environmental tobacco smoke. the Third National Health and Nutrition Examination Survey, 1988-91. Journal of the American Medical Association 1996; 275: 1233-40.
15. Breese CR, Marks MJ, Logel J, Adams CE, Sullivan B, Collins AC, et al. Effect of smoking history on [3 H] nicotine binding in human postmortem brain. Journal of Pharmacology and Experimental Therapy 1997; 282: 7-13.
16. 3H]-acetylcholine to nicotinic receptors. Neuropharmacology 1985; 24: 527-31.
17. 3 H]-nicotine binding sites. Synapse 1995; 21: 281-8.
18. Martyn JAJ, White DA, Gronert DA, Jaffe LS, Ward JM. Up- and down-regulation of skeletal muscle acetylcholine receptors. Effects on neuromuscular blockers. Anesthesiology 1992; 76: 822-43.
19. Su C. Actions of nicotine and smoking on circulation. Pharmacology and Therapeutics 1982; 17: 129-41.
20. Kenny PJ, Markou A. Neurobiology of the nicotine withdrawal syndrome. Pharmacology, Biochemistry and Behavior 2001; 70: 531-49.
21. Jones RM, Rosen M, Selymour L. Smoking and anaesthesia. Anaesthesia 1987; 42: 1-2.
22. Russel MA, Jarvis M, Iyer R, Feyerabend C. Relation of nicotine yield of cigarettes to blood nicotine concentrations in smokers. British Medical Journal 1980; 280: 972-6.
23. Porchet HC, Benowitz NL, Shainer LB, Copeland JR. Apparent tolerance to the acute effect of nicotine results in part from distribution kinetics. Journal of Clinical Investigation 1987; 80: 1466-71.
24. Nel MR, Morgan M. Smoking and anaesthesia revisited. Anaesthesia 1996; 51: 309-11.
25. Tassonyi E, Charpantier E, Muller D, Dumont L, Bertrand D. The role of nicotinic acetylcholine receptors in the mechanism of anesthesia. Brain Research Bulletin 2002; 57: 133-50.
26. Clarke P. The central pharmacology of nicotine: Electrophysiological approaches. In: Wonnacott S, Russell M, Stolerman J, eds. Nicotine Psychopharmacology: Molecular, Cellular and Behaviour Aspects. Oxford: Oxford Science Publications, 1990: 158-93.
27. Knott V. Electroencephalographic characterization of cigarette smoking behavior. Alcohol 2001; 24: 95-7.
28. Bell JK, Laasch HU, Wilbraham L, England RE, Morris JA, Martin DF. Bispectral index monitoring for conscious sedation in intervention: better, safer, faster. Clinical Radiology 2004; 59: 1106-13.
29. Gilbert D, McClernon J, Rabinovich N, et al. EEG, physiology and task-related mood fail to resolve across 31 days of smoking abstinence: relations to depressive traits, nicotine exposure and dependence. Experimental and Clinical Psychopharmacology 1999; 7: 427-43.
30. Chiodini FC, Tassonyi E, Hulo S, Bertrand D, Muller D. Modulation of synaptic transmission by nicotine and nicotinic antagonists in hippocampus. Brain Research Bulletin 1999; 48: 623-8.